Avecho Biotechnology Ltd (AVE) - Total Liabilities

Latest as of June 2026: AU$6.50 Million AUD ≈ $4.60 Million USD

Based on the latest financial reports, Avecho Biotechnology Ltd (AVE) has total liabilities worth AU$6.50 Million AUD (≈ $4.60 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Avecho Biotechnology Ltd (AVE) asset resilience to evaluate the company's liquid asset resilience ratio.

Avecho Biotechnology Ltd - Total Liabilities Trend (1993–2025)

This chart illustrates how Avecho Biotechnology Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Avecho Biotechnology Ltd (AVE) total assets.

Avecho Biotechnology Ltd Competitors by Total Liabilities

The table below lists competitors of Avecho Biotechnology Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Chips&Media Inc KQ:094360	Korea	₩12.31 Billion
Sukhjit Starch & Chemicals Limited NSE:SUKHJITS	India	Rs6.04 Billion
Byuksan Corp KO:007210	Korea	₩303.73 Billion
Y/KNOT S.A. AT:YKNOT	Greece	€29.83 Million
High Roller Technologies, Inc. NYSE MKT:ROLR	USA	$9.46 Million
Mistral Gayrimenkul Yatirim Ortakligi AS IS:MSGYO	Turkey	TL1.72 Billion
Big Sunshine Co Ltd TW:1475	Taiwan	NT$633.98 Million
Pollux Properti Indonesia Tbk PT JK:POLL	Indonesia	Rp605.94 Billion

Liability Composition Analysis (1993–2025)

This chart breaks down Avecho Biotechnology Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Avecho Biotechnology Ltd balance sheet quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.38	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	3.41	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.77	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Avecho Biotechnology Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Avecho Biotechnology Ltd (1993–2025)

The table below shows the annual total liabilities of Avecho Biotechnology Ltd from 1993 to 2025.

Year	Total Liabilities	Change
2025-12-31	AU$5.55 Million ≈ $3.92 Million	+221.15%
2024-12-31	AU$1.73 Million ≈ $1.22 Million	+83.43%
2023-12-31	AU$941.54K ≈ $666.20K	+2.27%
2022-12-31	AU$920.66K ≈ $651.42K	+29.79%
2021-12-31	AU$709.36K ≈ $501.92K	+1.31%
2020-12-31	AU$700.17K ≈ $495.41K	+25.90%
2019-12-31	AU$556.12K ≈ $393.49K	-38.35%
2018-12-31	AU$902.04K ≈ $638.25K	-50.87%
2017-12-31	AU$1.84 Million ≈ $1.30 Million	+7.52%
2016-12-31	AU$1.71 Million ≈ $1.21 Million	-5.97%
2015-12-31	AU$1.82 Million ≈ $1.28 Million	-3.04%
2014-12-31	AU$1.87 Million ≈ $1.33 Million	-14.36%
2013-12-31	AU$2.19 Million ≈ $1.55 Million	+44.93%
2012-12-31	AU$1.51 Million ≈ $1.07 Million	-58.44%
2011-12-31	AU$3.63 Million ≈ $2.57 Million	-75.40%
2010-12-31	AU$14.76 Million ≈ $10.44 Million	-15.04%
2009-12-31	AU$17.38 Million ≈ $12.29 Million	-1.48%
2008-12-31	AU$17.64 Million ≈ $12.48 Million	-53.29%
2007-12-31	AU$37.76 Million ≈ $26.72 Million	-0.69%
2006-12-31	AU$38.02 Million ≈ $26.90 Million	-2.35%
2005-12-31	AU$38.94 Million ≈ $27.55 Million	+4702.46%
2004-12-31	AU$810.73K ≈ $573.64K	+3127.69%
2003-12-31	AU$25.12K ≈ $17.77K	-17.24%
2002-12-31	AU$30.35K ≈ $21.47K	-46.21%
2001-12-31	AU$56.42K ≈ $39.92K	-69.54%
2000-12-31	AU$185.25K ≈ $131.08K	+156.71%
1999-12-31	AU$72.16K ≈ $51.06K	+117.59%
1998-12-31	AU$33.16K ≈ $23.47K	-54.87%
1997-12-31	AU$73.48K ≈ $51.99K	-98.74%
1996-12-31	AU$5.84 Million ≈ $4.13 Million	+4.60%
1995-12-31	AU$5.58 Million ≈ $3.95 Million	+1368.16%
1994-12-31	AU$380.00K ≈ $268.87K	-73.95%
1993-12-31	AU$1.46 Million ≈ $1.03 Million	--

About Avecho Biotechnology Ltd

AU:AVE Australia Biotechnology

Market Cap

$54.68 Million

AU$77.27 Million AUD

Market Cap Rank

#21673 Global

#752 in Australia

Share Price

AU$0.02

Change (1 day)

-4.76%

52-Week Range

AU$0.01 - AU$0.03

All Time High

AU$0.04